在Acinetobacter baumannii中的β-乳酸目标蛋白的独特属性与开发新抗生素相关
Seungil Han1, Nicole Caspers, Richard P Zaniewski
1Pfizer Worldwide Research, Eastern Point Road, Groton, Connecticut 06340, USA. seungil.han@pfizer.com
Journal of the American Chemical Society
|November 5, 2011
概括
对Acinetobacter baumannii青素结合蛋白 (PBPs) 的结构洞察力揭示了抗生素如何与这些关键标相互作用. 这项研究有助于理解和对抗多抗药性细菌感染.
科学领域:
- 微生物学 微生物学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 多药耐药的Acinetobacter baumannii对人类健康构成重大威胁.
- 细菌感染的有效治疗受到抗生素耐药性的阻碍.
- 了解抗生素向相互作用对于开发新疗法至关重要.
研究的目的:
- 为了确定Acinetobacter baumannii与β-乳酸抗生素复合的青素结合蛋白 (PBPs) 的晶体结构.
- 阐明针对A. baumannii的抗生素活性的结构基础.
- 为了指导新型抗菌剂的合理设计.
主要方法:
- 使用X射线晶体学来解决A. baumannii的PBP1a和PBP3的结构.
- 进行了动力学,生物物理和计算分析.
- 对比A. baumannii的PBP3结构与其Pseudomonas aeruginosa的结构.
主要成果:
- 据报道,A. baumannii PBPs的第一个晶体结构被四种beta-lactam抗生素共同无活化.
- 在A. baumannii的PBP1a结构中发现了一个新域.
- 溶解效应对PBP3-抗生素复合物的热稳定性有显著的贡献.
结论:
- 结构,生物物理和计算数据合理化了抗生素性能差异.
- 这些发现为设计针对A. baumannii的改进型抗生素提供了基础.
- 这项工作提高了我们对抗生素耐药性机制的理解.
相关概念视频
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
00:57Antibiotic Selection
Overview